News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Pfizer Inc. (PFE)'s Cancer Drug Sutent Linked to Severe Skin Reactions



9/9/2013 8:05:47 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

The manufacturer of a drug used to treat several types of cancer is warning that the medication has been linked with rare but potentially fatal skin rashes. Sutent, made by Pfizer Canada Inc., is used to treat cancers of the stomach and bowels, kidney, and pancreas. In a Health Canada advisory Friday, the company said Sutent (sunitinib malate) has been associated in some people with severe skin rashes, among them Stevens-Johnson syndrome and toxic epidermal necrolysis.

Help employers find you! Check out all the jobs and post your resume.

Read at CTV.ca
Read at CBC
Read at News Release


comments powered by Disqus
CTV.ca
CBC
News Release
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES